---
category: news
title: "Roche, aiming to make better gene therapies, turns to an emerging startup"
excerpt: "The Swiss pharma is the third large drugmaker to partner with Harvard spinout Dyno Therapeutics, a small biotech aiming to improve gene therapy technology."
publishedDateTime: 2020-10-14T15:03:00Z
originalUrl: "https://www.biopharmadive.com/news/roche-dyno-gene-therapy-deal/586993/"
webUrl: "https://www.biopharmadive.com/news/roche-dyno-gene-therapy-deal/586993/"
type: article
quality: 38
heat: 38
published: false

provider:
  name: BioPharma Dive
  domain: biopharmadive.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.biopharmadive.com/user_media/cache/5d/7c/5d7cb9b442f6969f3b73b5d122100ebb.jpg"
    width: 770
    height: 364
    isCached: true

related:
  - title: "Dyno sparks a $1.8B deal with Roche to develop CNS therapies"
    excerpt: "Privately held Dyno Therapeutics Inc., an early stage biotech company applying artificial intelligence to gene therapy, entered a collaboration and license agreement with Spark Therapeutics Inc. that could bring Dyno milestone payments exceeding $1."
    publishedDateTime: 2020-10-14T23:14:00Z
    webUrl: "https://www.bioworld.com/articles/498961-dyno-sparks-a-18b-deal-with-roche-to-develop-cns-therapies"
    type: article
    provider:
      name: BioWorld
      domain: bioworld.com
    quality: 24
    images:
      - url: "https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Neurology/CNS-illustration.png?height=635&t=1602701261&width=1200"
        width: 847
        height: 635
        isCached: true
  - title: "Dyno Therapeutics Enters Collaboration and License Agreement With Roche to Develop Next-Generation AAV Gene Therapy Vectors for CNS Diseases and Liver-Directed Therapies"
    excerpt: "Dyno Tx Enters Collaboration and License Agreement with Roche to Develop Next-Gen AAV Gene Therapy Vectors for CNS Diseases, Liver-Directed Therapies"
    publishedDateTime: 2020-10-15T03:05:00Z
    webUrl: "https://www.businesswire.com/news/home/20201014005248/en/Dyno-Therapeutics-Enters-Collaboration-and-License-Agreement-With-Roche-to-Develop-Next-Generation-AAV-Gene-Therapy-Vectors-for-CNS-Diseases-and-Liver-Directed-Therapies"
    type: article
    provider:
      name: Business Wire
      domain: businesswire.com
    quality: 0
    images:
      - url: "https://mms.businesswire.com/media/20201014005248/en/790645/23/Dyno-Logo-Final-050820.jpg"
        width: 1200
        height: 627
        isCached: true

secured: "yxWHWSPi8ejK5zpqlhbgcXDbFAOdbJQ4SxmUoKnFYGMyDr1RSBh1eNgkrh+27By4fSYF/VgxgECj+zRqSz2rqy/TuCydWp1/HC6aVHALXFGJEBzgPnuXiDKBAHSKweOvWM+OeuHgOyVpQQZSUrS1c6h2r8bFBDNdAwxhFqCRAuCQ6//95yfLC0RWpBOJvMNXvFXCOPjZ9hiPAmWIsAbQxYUVPUQ7TjYfMCpaiakNsLxKdSzGWpNXjsDw++++lGRxay/W0wG+00qWlLgGbxDevApBC3+ZFV/jnbU9uYG6x+FkRQ41CSgfnjRaE51ZV/ogmSusfYIA4WbrzJCPKDW7ghb6zpDVAmhXrbkLfxeyJOA=;QdvGnmOCAK2rdDgO4la1rQ=="
---

